Drug Discovery and Development: TEI Biosciences, Inc.

• Publication date: June 2012
• Report size: 16 pages

This report is a source for data, analysis and actionable intelligence on the TEI Biosciences, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product description, fun...

This report is a source for data, analysis and actionable intelligence on the TEI Biosciences, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Blood Supply, Tissue Banking And Transplantation Industry in the United States

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
TEI Biosciences, Inc. - Major Products and Services 5
TEI Biosciences, Inc. Pipeline Products by Equipment Type 6
TEI Biosciences, Inc. Pipeline Products by Development Stage 7
TEI Biosciences, Inc. Pipeline Products by Therapy Area 8
Biologic Vascular Graft 9
Product Status 9
Product Description 9
Injectable Dermal Filler 9
Product Status 9
Product Description 9
Matrix For Abdominal Wall Reconstruction 9
Product Status 9
Product Description 9
TEI Biosciences, Inc. - Top Competitors 11
TEI Biosciences, Inc. - Key Executives 12
TEI Biosciences, Inc. - Operations and Subsidiaries 13
Head Office 13
Recent Developments 14
February 18, 2010: TEI Biosciences Receives APMA Approval For PriMatrix 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15


List of Tables

TEI Biosciences, Inc., Major development 1
TEI Biosciences, Inc. Key Pipeline Products by Equipment Type 1
TEI Biosciences, Inc. Key Pipeline Products by Therapy Area 1
TEI Biosciences, Inc. Key Pipeline Products by Development Stage 1
TEI Biosciences, Inc. Key Pipeline Products by Trial Phase 1
TEI Biosciences, Inc., Major development 4
TEI Biosciences, Inc., Major Products and Services 5
TEI Biosciences, Inc. Number of Pipeline Products by Equipment Type 6
TEI Biosciences, Inc. Pipeline Products by Equipment Type 6
TEI Biosciences, Inc. Number of Pipeline Products by Development Stage 7
TEI Biosciences, Inc. Pipeline Products by Development Stage 7
TEI Biosciences, Inc. Number of Pipeline Products by Therapy Area 8
TEI Biosciences, Inc. Pipeline Products by Therapy Area 8
Biologic Vascular Graft - Product Status 9
Biologic Vascular Graft - Product Description 9
Injectable Dermal Filler - Product Status 9
Injectable Dermal Filler - Product Description 9
Matrix For Abdominal Wall Reconstruction - Product Status 9
Matrix For Abdominal Wall Reconstruction - Product Description 10
TEI Biosciences, Inc., Key Executives 12


List of Figures

TEI Biosciences, Inc. Pipeline Products by Equipment Type 6
TEI Biosciences, Inc. Pipeline Products by Development Stage 7
TEI Biosciences, Inc. Pipeline Products by Therapy Area 8

Companies mentioned BlueSky Medical Group, Inc.
Brown Medical Market
Collagen Matrix, Inc.
Dynatronics Corporation
Southwest Technologies, Inc.
Synovis Surgical Innovations
Brennen Medical, LLC
Advanced BioHealing, Inc.
LifeCell Corporation
Atrium Medical Corporation